← Leaderboards
Christopher P Smith
Michael E Debakey Va Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2013–16$1$1$1$0$0
'13
'14
'15
'16
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Michael E Debakey Va Medical Center
Same institution · by research overlap
- Felicia Skelton$320,000
Others in their field
Top investigators on “Clinical Efficacy”
- Barton F Haynes · Duke University$706,372,479
- Lawrence Corey · Fred Hutchinson Cancer Center$702,186,957
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$527,314,031
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$379,406,045
- Dennis R. Burton · Scripps Research Institute$256,423,824
- Wafaa M. El-Sadr · Columbia University Health Sciences$218,548,214
Research focus
Clinical EfficacyData Coordinating CenterAdverse EffectsCholinergicAfferent NerveAdrenergic Alpha-AntagonistsAmericanAndrogensAdrenergic AgentsAnimal DataAnimal ModelAnimalsApoptosisAftercareAtrophicBenign Prostatic HypertrophyBiological MarkersBiopsyAngiogenesisAffectCategoriesCellsChemical ModelsDenervation
Grant awards (4)
OnabotulinumtoxinA (onaVoNT-A) vs Oral Tamsulosin for PBH & LUTS (#02-10-10-05)$0
I01 · FY2016 · VA · contact PI
OnabotulinumtoxinA (onaVoNT-A) vs Oral Tamsulosin for PBH & LUTS (#02-10-10-05)$0
I01 · FY2015 · VA · contact PI
OnabotulinumtoxinA (onaVoNT-A) vs Oral Tamsulosin for PBH & LUTS (#02-10-10-05)$0
I01 · FY2014 · VA · contact PI
OnabotulinumtoxinA (onaVoNT-A) vs Oral Tamsulosin for PBH & LUTS (#02-10-10-05)$0
I01 · FY2013 · VA · contact PI